Programme 2018 | Cardio-metabolic Dialogues 2

2018 Meeting Programme

Morning

10:00 – 10:30	Registration and Coffee
10:30 – 10:35	Welcome and Introduction	Professor Neil Poulter and Professor Kausik Ray, Imperial College London
10:35 – 11:00	CVD prevention in DM – The importance of BP lowering	Professor Neil Poulter Imperial College London
11:00 – 11:30	The role of SGLT2s: Trial evidence and future prospects	Professor Kausik Ray Imperial College London
11:30 – 12:00	The role of GLP1-As: Trial evidence and future prospects	Professor Miles Fisher Glasgow Royal Infirmary
12:00 – 12:30	The role of other glucose lowering therapies: Trial evidence and future prospects	Professor Clifford J Bailey Aston University
12:30 – 13:00	Renal outcomes in glucose-lowering trials	Professor David Wheeler University College London
13:00 – 13:40	Lunch

13:40 – 14:10	Hypoglycaemia and CVD	Dr Mark Evans University of Cambridge
14:10 – 14:30	Breakout groups (8-10 people per group) a. Treatment pathway for optimising 2ry prevention of CV events in T2DM b. Optimal BP management in T2DM/CKD/Post CV events. Targets/thresholds/drugs? c. Optimal drug sequencing for glucose lowering
14:30 – 15:15	Groups Feedback
15:15 – 15:45	Heart failure and T2DM	Professor Theresa A McDonagh King’s College London
15:45 – 16:15	Lipid lowering for optimal CVD prevention	Professor Kausik Ray Imperial College London
16:15 – 17:00	Keynote lecture Cardiometabolic disease: burden and management	Professor David Wood Imperial College London
17:00 – 18:00	Close of meeting and refreshments